Hildred
Edit

Hildred

https://www.hildred.com
Last activity: 27.08.2026
Active
Invests in categories: AICareDiagnosticsHealthcareHealthTechManagementMedtechServiceSkinTechnology
Hildred™ is a New York City-based private equity investment firm focused on middle-market companies across the world of healthcare.
News
59
Portfolio
16
Persons
24
Mentions
9
Investment Stage: Private Equity

Portfolio 16

Show more

Persons 24

DateFirst NameLast NameTitleLinkedInLocation
-ElizabethSotoFinancial ...-
-BobJacksonOperating ...-
-BenSamitPrincipallinkedin.c...-
-AlexandraAielloSenior Ana...linkedin.c...-
-RobHealyOperating ...-
-EdwardWickhamAssociate-
-AndrewGoldmanCo-Founder...linkedin.c...-
-RaveenaRahamanExecutive ...linkedin.c...-
-StephenHallenbeckPartnerlinkedin.c...-
-KevinReganVice Presi...linkedin.c...-
Show more

News 59

DateTitleDescription
25.08.2026Tobe Cohen Named Chief Executive Officer of Hyland’s Consumer Health and Hello Bello Consumer WellnessFormer CEO Will Righeimer to Remain with the Company as an Executive Advisor and Board Member LOS ANGELES--(BUSINESS WIRE)--Hyland’s Consumer Health (“Hyland’s”), a leading pediatric-focused consumer health and wellness company that compris...
13.08.2026DermCare Management and U.S. Dermatology Partners Complete Strategic Transaction to Combine Operations, Creating One of the Largest Dermatology Group Practices in the U.S.Combination Builds on a Shared Commitment to Physician-Led, Patient-First Care and to Supporting the Teams Who Deliver It HOLLYWOOD, Fla. & DALLAS--(BUSINESS WIRE)--DermCare Management, LLC (“DermCare”), a leader in specialized dermatol...
07.01.2026OrangeTwist Announces Strategic Alliance with SBC Medical Group Holdings and Expansion to 24 Locations Across 6 States to Support Long-Term Growth InitiativesNEWPORT BEACH, Calif.--(BUSINESS WIRE)--OrangeTwist, a leading U.S. med spa platform delivering cutting-edge aesthetic and wellness treatments through a hospitality-driven clinical experience, has announced a strategic alliance and minority...
17.12.2025Hildred Provides Tebra with $250 Million in New Equity and Debt Financing to Accelerate its R&D in AI and AutomationNEW YORK – December 17, 2025 – Hildred, a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies, today announced that it has provided Tebra, the all-in-one EHR+ platform trusted by over 1...
24.11.2025AleraCare and Pure Healthcare Complete Merger, Creating a Leading National Platform for Ambulatory Infusion and Specialty CarePHOENIX & TAYLORSVILLE, Utah--(BUSINESS WIRE)--AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and Pure Healthcare, a leading national medical group that delivers healthcare services for indivi...
05.11.2025Hildred Named to Inc.’s 2025 List of Founder-Friendly InvestorsNEW YORK--(BUSINESS WIRE)--Hildred, a lower middle-market healthcare private equity firm, today announced that it has been named to Inc.'s 2025 Founder-Friendly Investors list. The prestigious list celebrates the investors that believe in b...
08.10.2025AleraCare Appoints Joseph Cosgrove as Chief Executive Officer and Member of the Board of DirectorsCompany Advances Toward Planned Merger with PURE Healthcare PHOENIX--(BUSINESS WIRE)--AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., today announced that its Board of Directors has unanimously app...
13.08.2025AleraCare and PURE Healthcare Announce Intent to MergeThe combined company will create a leading ambulatory infusion platform with more than 75 outpatient locations across 14 states throughout the U.S. PHOENIX & TAYLORSVILLE, Utah--(BUSINESS WIRE)--AleraCare, a leading provider of infusion...
07.02.2025Crown Laboratories Completes Acquisition of Revance TherapeuticsNEW YORK--(BUSINESS WIRE)--Yesterday, Crown Laboratories, Inc. ("Crown"), a Hildred Capital portfolio company and privately held, global innovative leader in the skincare industry, announced the closing of its acquisition of Revan...
06.02.2025Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. Announce Exit from Pharmaceutics International, Inc.NEW YORK--(BUSINESS WIRE)--A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics International, ...
Show more

Mentions in press and media 9

DateTitleDescription
19.12.2025Tebra Secures $250M to Redefine Healthcare AI for Independent PracticesTebra closed a $250 million funding round. The investment targets AI and automation for independent healthcare providers. It propels Tebra's EHR+ platform. The system shifts from a "record" function to an "action" engine...
17.12.2025Hildred Provides Tebra with $250 Million in New Equity and Debt Financing to Accelerate its R&D in AI and AutomationNEW YORK – December 17, 2025 – Hildred, a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies, today announced that it has provided Tebra, the all-in-one EHR+ platform trusted by over 1...
17.12.2025Tebra: $250 Million Funding Raised To Accelerate AI Across EHR, Billing Automation And Practice MarketingTebra has closed $250 million in new equity and debt financing to accelerate research and development in AI and automation for independent healthcare practices. The Newport Beach, California-based company said the oversubscribed round will ...
17.12.2025Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered AutomationWhat You Should Know: – Tebra has raised $250M in new equity and debt financing, led by Hildred, to transform its EHR+ platform from a passive “System of Record” into an active “System of Action” using AI. – The funding will accelerate the ...
17.12.2025Tebra Receives $250M in FundingTebra, a Newport Beach, CA-based EHR+ platform provider, received $250m in new financing. The financing was led by existing investor Hildred as well as a debt facility provided by J.P. Morgan, with participation from existing investors Mont...
13.01.2025Hildred Capital Announces Oversubscribed Final Close of Hildred Equity Partners III with Capital Commitments in Excess of $800 MillionNEW YORK – January 13, 2025 – Hildred Capital Management, LLC ("Hildred"), a lower middle-market healthcare private equity firm, today announced the successful final closing of its third fund, Hildred Equity Partners III (the “Fun...
28.03.2024Hildred Capital Announces Close of Multi-Asset Continuation Fund with Capital Commitments in Excess of $750 MillionNEW YORK--(BUSINESS WIRE)--Hildred Capital, (“Hildred”) a healthcare-focused private equity firm that specializes in partnering with middle-market companies, today announced the closing of a multi-asset continuation fund led by Lexington Pa...
15.02.2022Hildred Capital Management Closes Hildred Equity Partners II Fund at $363 MillionNEW YORK--(BUSINESS WIRE)--Hildred Capital Management LLC (“Hildred”), a New York based private equity firm, today announced that it has closed its first institutional fund, Hildred Equity Partners II (the “Fund”) with total commitments of ...
08.02.2022HealthCare.com® Extends Previously Announced $180M Financing with Additional $31.5M Investment from Hildred CapitalNEW YORK & MIAMI--(BUSINESS WIRE)--HealthCare.com, a leading data-driven insurtech platform, announced today the extension of its recent Series C equity round, which was led by Oaktree Capital Management, L.P. (“Oaktree”) as well as exi...

Reviews 0

Sign up to leave a review

Sign up Log In